Epitalon (also spelled Epithalon or Epithalone; sequence Ala-Glu-Asp-Gly, "AEDG") is a synthetic tetrapeptide studied in longevity and anti-ageing research. It is a lab-made version of a peptide originally isolated from the pineal gland. Researchers study it mainly for two reasons: its reported ability to activate telomerase (the enzyme that maintains the protective caps on the ends of chromosomes) and its effect on pineal gland function and melatonin rhythm.
Unlike the weekly metabolic peptides, epitalon is typically studied in short daily courses — for example 5–10 mg per day for 10–20 days, repeated a few times per year. This guide covers that course structure, reconstitution of the 10 mg vial, and what the evidence does and does not show. It is an educational reference, not medical advice.
Epitalon is studied as short, repeated courses rather than a continuous daily peptide. The idea in the research literature is that the peptide acts as a signal that shifts gene expression, so a defined course is followed by a long break before the next one.
| Approach | Daily Dose | Course Length | Frequency |
|---|---|---|---|
| Conservative | 5 mg/day | 10 days | 2–3 courses per year |
| Standard | 5–10 mg/day | 10–20 days | 2–3 courses per year |
| Extended | 10 mg/day | 20 days | 1–2 courses per year |
LA LAB stocks epitalon as a 10 mg vial. Reconstitute with 3.0 mL bacteriostatic water for a concentration of 3.33 mg/mL. Read across the row for your daily dose.
| Daily Dose | Volume | Units (U-100) | Days / Vial |
|---|---|---|---|
| 5 mg | 1.5 mL | 150 units | 2 |
| 10 mg | 3.0 mL | 300 units | 1 |
Epitalon is a peptide bioregulator — the research idea is that very short peptides can bind DNA and influence which genes are switched on. Two mechanisms dominate the literature.
Cell-culture studies (Khavinson and colleagues) reported that epitalon can induce telomerase activity, the enzyme that rebuilds telomeres — the protective caps on the ends of chromosomes that shorten with each cell division. Longer telomere maintenance is the headline reason epitalon is studied in ageing research. This is a laboratory finding, not a proven human anti-ageing effect.
Epitalon is derived from epithalamin, a pineal-gland peptide preparation. Research suggests it helps normalise melatonin secretion and circadian rhythm, particularly where the pineal gland's output has declined with age. Reported downstream effects include improved sleep-wake rhythm and antioxidant activity.
Because it acts as a signalling peptide rather than a circulating hormone, epitalon's plasma half-life is very short (minutes). That is why it is studied as daily courses — the effect is attributed to gene-expression changes, not to a sustained blood level.
In the published research, epitalon has generally been reported as well tolerated, with few adverse effects noted at the doses studied. However, the evidence base is the key caveat, not the side-effect profile.
| State | Storage | Notes |
|---|---|---|
| Lyophilised (powder), sealed | -4°F (-20°C) or below | Long-term; up to 12+ months. |
| Lyophilised (powder), sealed | 35.6–46.4°F (2–8°C) | Several months. |
| Reconstituted (liquid) | 35.6–46.4°F (2–8°C) | Use within the course (2–3 weeks); protect from light. |
Epitalon is not approved as a medicine by the FDA, EMA, SAHPRA, or other major regulators. It is sold as a research-grade peptide for laboratory use only and is not intended for human consumption. Buyers are responsible for COA verification, correct storage, and compliance with local research regulations.
Epitalon comes almost entirely from the work of one Russian group, led by Vladimir Khavinson, over several decades. No Western trial has replicated any of it. The claims made for it — telomerase activation, extended lifespan — are among the biggest of any compound sold, and the evidence behind them is among the thinnest.
| Reported | Detail |
|---|---|
| Injection-site reactions | The most commonly reported. |
| Drowsiness | Reported by some; epitalon is linked to melatonin regulation. |
| Vivid dreams or changed sleep | Frequently reported, consistent with a pineal mechanism. |
| Nothing noticeable | The most common report. The claimed effects are cellular and not something you would feel. |
| Situation | Why |
|---|---|
| Active cancer, or a recent history | Avoid. Telomerase activation is one of the mechanisms by which cancer cells evade normal cell death. This is the central theoretical risk and it has not been studied. |
| Pregnancy or breastfeeding | Avoid. No data. |
| Under 18 | Avoid. No data. |
| Expecting it to extend your life | No human trial has demonstrated this. Anyone selling it on that basis is going far beyond the evidence. |